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Abstract
Background—Adipose tissue is an endocrine organ that influences many metabolic processes 
and accumulates in different depots, including the bone marrow. While the negative associations 
between visceral fat (VF) or subcutaneous fat (SF) and cardiovascular disease (CVD) risks are 
well known, the relation between marrow fat (MF) and metabolic risk is unexplored.
Objectives—We examined the relations between these three fat depots and whether CVD risks 
are associated to marrow adiposity.
Design—observational cross sectional study
Subjects and Methods—Computed tomography was used to measure VF, SF and MF depots 
in 131 healthy young adults (60 females, 71 males; 16-25 years of age). Weight, body mass index 
(BMI), waist and hip circumferences, blood pressure (BP), carotid intima media thickness (CIMT) 
and serum levels of lipids, glucose and insulin were also measured.
Results—Regardless of gender, MF was not associated to values of VF or SF, anthropometric 
measures, or lipid or carbohydrate serum levels (P >0.05 for all). In contrast, VF was associated to 
SF (r’s= 0.74 for females, 0.78 for males; both P’s <0.0001) and these depots were related to 
anthropometric parameters (r’s between .69 and .87; all P’s <0.0001) and to most measures of 
lipids, glucose or insulin (r’s between .25 and .62).
Conclusions—Marrow adiposity in young men and women is independent of visceral and 
subcutaneous fat, and is not associated to CVD risk. These findings do not support the concept 
that marrow adiposity is involved in the comorbidities related to fat accumulation in other 
compartments.
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INTRODUCTION
Fat tissue is a complex endocrine organ, secreting multiple hormones, influencing many 
metabolic processes, and amassing at various sites, including the subcutaneous and intra-
abdominal tissues and the marrow cavity of bones. In excess, it gives rise to several 
comorbidities (1). A wealth of epidemiologic data links a growing number of negative 
health outcomes, such as hypertension, insulin resistance, type 2 diabetes, dyslipidemia, the 
metabolic syndrome, and CVD risk to the progressive accumulation of fat. Despite 
differences in histology, physiology, and gene expression profile among fat depots, it is 
generally believed that excessive fat accumulation at any site has similar negative health 
connotations (2-5). For example, both intra-abdominal and subcutaneous fat depots are 
related to insulin resistance and dyslipidemia, albeit to different degrees (6-10).
We recently found an inverse relation between fat in the marrow cavity and the amount of 
bone in the skeleton of young healthy subjects. Unexpectedly, there were no relations 
between measures of marrow adiposity with weight, BMI or total body fat as measured by 
dual energy x-ray absorptiometry (DXA) (11). These findings suggest that marrow fat may 
be an independent fat compartment with potentially different metabolic functions; consistent 
with studies in animal models reporting no relation between body size or insulin secretion 
and marrow adiposity (12). However, the possible association between marrow fat and 
blood pressure (BP), measures of carotid wall thickness and carbohydrate or lipid 
metabolism in humans is largely unexplored, and no previous study has assessed the relation 
between marrow adiposity and CVD risk factors. We examined the relations between 
marrow fat and subcutaneous and visceral adiposity using computed tomography (CT) and 
between marrow fat and BP, carotid wall thickness, fasting levels of insulin, glucose and 
lipids in healthy young males and females.
SUBJECTS AND METHODS
Subjects
The participants were 131 healthy young adults (60 females, 71 males; 16-24.9 years of age) 
who were recruited from schools and colleges in the Los Angeles area. The investigational 
protocol was approved by the hospital institutional review board and informed consent was 
obtained. Candidates for this study were excluded if they had a diagnosis of any underlying 
disease or chronic illness, if they had been ill for >2 weeks during the previous 6 months, if 
they had been admitted to the hospital at any time during the previous 3 years, or if they 
were taking any medications regularly. Females who were pregnant were also excluded. All 
potential candidates underwent a physical examination by a pediatric endocrinologist and 
only those who had achieved sexual maturity (Tanner stage V of sexual development) were 
included (13). Thereafter, height, weight, BP, body mass index (BMI), waist and hip 
circumferences and the waist-to-hip ratio were determined. The waist-to-hip ratio was 
calculated as a surrogate of central adipose distribution.
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Carotid Ultrasonography
All studies were acquired by the same specialized ultrasound (US) technologist using the 
Acuson Sequoia 512 mainframe (Acuson Corp., California, USA) equipment and a high-
resolution 15L8 MHz linear-array transducer following a predetermined standardized 
scanning protocol. The patients were studied in the supine position with the head turned 
slightly toward the side examined. Images of the arterial wall were obtained from the 
posterior walls of both common carotids one centimeter below the carotid bulb (bifurcation) 
during three complete and independent cardiac cycles. An automated computerized edge 
detection software package developed by Siemens (Siemens Medical Solutions USA, 
Pennsylvania, USA) was used to determine carotid intima-media thickness (CIMT) values in 
the frames of each cycle depicting the narrowest and widest vessel diameters. The mean 
measure obtained from three independent cardiac cycles at the maximum and minimum 
arterial diameters in both carotids was used for analysis. All examinations were digitally 
stored and analyzed by the same researcher. The intraclass correlations for CIMT 
determinations obtained in three different cardiac cycles are between .92-.98 (14).
Blood Pressure
Readings of BP were taken after a 10-minute rest using a standard mercury 
sphygmomanometer (Critikon Dura-cuf, GE Medical Systems, Wisconsin, USA) 
immediately prior to, and immediately following, the US examination. The subject was as 
relaxed as possible and was instructed not to talk during the measurement procedure. BP 
was measured in a supine position from the right and left brachial arteries below the level of 
the right atrium and the average of all these readings was used for analysis. Subjects whose 
BP was outside the mean age adjusted normal values were excluded from further evaluation 
(15).
CT Measurements of Fat
Subjects underwent CT measurements of fat accumulation using a General Electric Hilite 
Advantage scanner (General Electric Healthcare, Milwaukee, WI) with the same 
standardized reference phantom for simultaneous calibration and with specially designed 
software for fat and bone measurements. All scans were obtained by the same CT 
technologist using the following technical factors: 80 kVp (abdomen) or 120 kVp (femur), 
70 mAs, 2 sec, and 10 mm slice thickness. The time required for CT examinations was 
approximately 10 minutes, and the radiation exposure of this limited CT study was 100–150 
mrem (1.0–1.5 mSv).
Measurements of the areas of visceral fat (VF; cm2) and subcutaneous fat (SF; cm2) were 
obtained at the umbilical level. For the purpose of this study, SF was defined as the amount 
of adipose tissue located between the skin and the rectus muscles of the abdomen, the 
external oblique muscles, the broadest muscles of the back and the erector muscles of the 
spine at the level of the umbilicus. VF was defined as the intraabdominal adipose tissue 
surrounded by the rectus muscles of the abdomen, the external oblique muscles, the lumbar 
quadrate muscle, the psoas muscles, and the lumbar spine at the same level. Measures of the 
fat density (FD) of the marrow canal were obtained at the midshaft of the femurs.
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CT numbers express the measure of the linear attenuation of the x-ray beam through the 
medium in that space and are defined as Hounsfield units (HU), using the linear attenuation 
coefficient of water (HU=0) and air (HU= -1000); using these parameters, HU for fat fall 
between a range of negative values (16). For the purpose of this study, CT values for FD in 
HU were converted into density values (g/cm3) based on previously published studies that 
calculated CT attenuation values for human tissues, including adipose tissue (17-19). 
Specifically, HU measures for all subjects were converted into mass density using a function 
taken from Schneider et al for CT ranges between -98 and 14; density = (1.018 + 0.893 × 
10-3HU)(g/cm3) (17). It should be stressed that, since marrow is comprised of hematopoietic 
tissue (+HU) with a density of 1.06 g/cm3, and fatty tissue (-HU) with a density of 0.92 
g/cm3, the higher the density of marrow tissue the lower the fraction of marrow fat (17). 
This fraction changes during growth and throughout life in a predictable and orderly age-, 
bone- and site-specific fashion (20-22). In contrast to the vertebral body and the 
metaphyseal regions of the long bones, the shaft of the femur contains no trabecular bone. 
Additionally, by 15 years of age, the marrow in the shaft of the long bones is mostly 
comprised of fat, and CT values for the density of the marrow at this site mainly reflect the 
tissue density of fat; although from menarche to menopause females are known to have 
more hematopoietic tissue in the marrow (23, 24). Hence, to avoid the confounding effects 
of blood conversion and trabecular bone, we chose to analyze the shaft of the long bones. 
Intra- and inter-coefficients of variation (CV) for repeated measurements of VF and SF 
ranged from 1.5% to 3.5% and were 1% for FD (11, 25).
Biochemical Determinations
After an overnight fast, blood samples were obtained. Glucose was analyzed by the Ortho 
vitros 950 via dry chemistry method and insulin by the Magic Light analyzer via 
immunochemiluminometric assay that utilizes paired antibodies selectively reactive to 
intrinsic insulin. Lipid profiles, including measures of triglycerides, total cholesterol and 
low, very low and high density lipoproteins (LDL, VLDL and HDL respectively), were 
determined using a direct measurement method for the enzymatic determination of 
cholesterol esters (26). Cardio-sensitive reactive protein (CRP) was measured by latex-
enhanced nephelometry. Using the Homeostasis Model Assessment (HOMA-IR) formula 
(insulin [mU/l] × glucose [mmol/l]) / 22.5, insulin resistance was calculated (27). The ratio 
between high-to-low lipoproteins was determined as surrogate of dyslipidemia (LDL
+VLDL/HDL).
Statistical Analyses
Student’s t test for unpaired data was used to compare mean values between genders, and 
simple correlations to investigate the association between the various fat compartments and 
age, anthropometric parameters, blood pressure, CIMT measures, glucose, insulin, lipids, 
CRP and bone measures. Multiple linear regressions were performed using the different fat 
measures as dependent variables, and BMI, the waist-to-hip ratio, and biochemical 
determinations as independent variables. The StatView® statistical software (SAS Institute 
Inc. Cary, NC, 27513, USA) was used for these analyses. Quantitative variables are 
expressed as mean ± standard deviation (SD).
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RESULTS
Table 1A shows age, anthropometric measurements, blood pressure, CIMT measures and 
CT values for fat in all study subjects. BMI ranged from 17.2-36 kg/m2, reflecting a 
distribution from normal weight to obesity according to CDC definition. Overall, 19.0% of 
the subjects were overweight, and 9.9% were obese. As expected, values for height, weight, 
waist circumference, waist-to-hip ratio, systolic BP and marrow adiposity were significantly 
greater in males, while those for SF and diastolic PB were greater in females; there were no 
gender differences in age, BMI, hip circumference, CIMT values or VF. Table 1B 
summarizes biochemical measures of carbohydrate and lipid metabolism and inflammatory 
markers; women had higher values for insulin, HOMA-IR and HDL cholesterol, whereas no 
gender differences were seen for glucose, LDL or VLDL cholesterol, or PCR. Due to higher 
values for HDL cholesterol, females also exhibited a more favorable lipoprotein ratio.
Regardless of gender, VF and SF were significantly associated with each other (r’s= 0.74 for 
females, 0.78 for males; both P’s <0.0001) and were each strongly related to weight, BMI, 
waist and hip circumferences, insulin, triglycerides and the low to high density lipoprotein 
ratio. Significant associations were found between VF and CIMT measures in males, but not 
in females (Table 2). In contrast, marrow adiposity was not related to measures of VF or SF, 
to any anthropometric parameters (Figure 1), to CIMT values or to any biochemical 
measures of carbohydrates or lipid metabolism (Tables 2 and 3); this was true for males and 
females (p=ns for all correlations). No significant associations were found between any of 
the three fat compartments and values for systolic or diastolic BP (r’s between -.20 and .11) 
or inflammatory profile; although CRP and VF showed a trend towards significance in both 
genders (both P’s = 0.06) (Table 2).
Multivariate regression analyses indicated that both BMI and HOMA-IR independently 
predicted SF in males, and that BMI and the low-to-high density lipoprotein ratio 
independently predicted VF in both females and males (Table 3).
DISCUSSION
Ample data indicate that the expansion of body fat has tremendous implications for 
metabolic health and is strongly associated to dyslipidemia and insulin resistance. However, 
compared to subcutaneous or abdominal fat depots, the relations between marrow adiposity 
and metabolic risk factors are largely unknown. In our study, we found that in healthy young 
males and females, CT measures of marrow adiposity at the midshaft of the femurs were not 
related to any anthropometric parameters or surrogates of adiposity, such as the waist-to-hip 
ratio, or to the amount of visceral or subcutaneous fat. Moreover, marrow adiposity was not 
associated to BP, measures of carotid wall thickness, fasting glucose, fasting insulin, insulin 
resistance, or lipid profile. To our knowledge, no previous study has assessed the relation 
between marrow adiposity and CVD risk factors.
In contrast, like others and as expected, we found that visceral and subcutaneous fat 
compartments were strongly associated with each other and with anthropometric and 
biochemical measures of metabolic risk. BMI was the main predictor of these two fat 
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depots, accounting for more than 50% and 70% of the variance of visceral and subcutaneous 
fat, respectively, regardless of gender. Moreover, HOMA-IR predicted 1.8% of the variance 
of SF in males, while the low-to-high lipoprotein ratio was predictive of VF in both females 
and males; 5.7% and 6.0%, respectively.
Our findings are consistent with previous studies in animal models indicating that marrow 
fat is not affected by insulin or long periods of starvation (12, 28). They are also in 
agreement with two previous studies in humans showing a lack of association between 
marrow adiposity and anthropometric or abdominal fat depots measures (29, 30); these 
investigations used a combination of DXA to measure abdominal adiposity and magnetic 
resonance (MR) techniques or histology to evaluate marrow fat, while, in the current study, 
we used CT to analyze this relation. Although no clinical investigations have previously 
assessed the relationships between marrow adiposity and energy metabolism, there is 
anecdotal evidence that marrow fat may be metabolically independent of other fat 
compartments. Indeed, the progressive loss of body weight in anorexia is associated to an 
increased amount of fat in the marrow, at least until extreme levels of thinness (31). 
Similarly, acquired lypodystrophy leads to a massive loss of body fat, specifically, of 
subcutaneous fat in the hips and thighs, and to a lesser degree, of visceral fat, yet marrow 
adiposity remains preserved (32).
Previous findings by us and others indicate marrow adiposity to be reciprocally related to 
the amount of bone in both the axial and the appendicular skeleton (11, 30, 33-35). Whether 
marrow and extraskeletal adipocytes arise from different clonal cells or share a common 
progenitor that undergoes specific proliferation and differentiation based on location, is yet 
to be elucidated. In this regard, the superficial and deep subcutaneous fat depots in swine 
were found to arise from two different progenitors, the perifollicular stromal cells and the 
mesenchyme, respectively (36).
The use of sophisticated imaging technology, the inclusion of both genders, the evaluations 
of multiple adiposity and metabolic biochemical measures and the examination of a 
homogeneous cohort of teenagers and young adults are strengths of this study. The cross-
sectional design is a major limitation, and further investigations will be needed to establish 
why skeletal and extra-skeletal adiposity are not related. Although in the current study we 
did not assess key determinants of fat accumulation, such as dietary and alcohol intake, 
since weight, BMI, waist circumference, hip circumference or their ratio were not related to 
marrow fat, it is unlikely that these variables influenced our results. Additionally, our results 
are limited to young adults who were not overly obese (BMI >36) and cannot be 
extrapolated to other age groups or populations. Lastly, while CT determinations of FD have 
not been validated in the same individuals with histomorphometry, previous in vitro studies 
have assessed the accuracy of CT measures of marrow adiposity (37).
In conclusion, marrow adiposity in the femurs of healthy teenagers and young adults is not 
related to visceral or subcutaneous fat depots, nor to metabolic or CVD risk factors. Our 
findings support the notion that the negative metabolic health outcomes known to be 
associated to obesity are independent of marrow fat.
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Figure 1. 
Correlations between CT values for marrow fat density and measures of visceral and 
subcutaneous fat areas and BMI in both males and females. Correlations are not statistically 
significant (P > 0.05).
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Table 1
A. Age, anthropometric parameters, blood pressure, CIMT and fat compartments measurements in 71 males 
and 60 females. B. Glucose, insulin and lipid profiles in 71 males and 60 females
Males Females
Means ± SD (range) Means ± SD (range)
Age (years) 19.0 ± 1.8 (16.0 – 24.3) 19.0 ± 2.1 (16.0 – 24.9)
Height (cm) † 172.8 ± 8.1 (152.0 – 190.5) 161.2 ± 6.4 (143.0 – 172.8)
Weight (kg) † 70.9 ± 12.3 (51.0 – 110.0) 61.2 ± 10.9 (45.5 – 92.0)
BMI (kg/m2) 23.8 ± 3.9 (17.2 – 36.0) 23.6 ± 4.1 (17.9 – 34.8)
Waist circumference (cm)* 81.6 ± 10.6 (63.6 – 114.0) 77.5 ± 9.4 (61.0 – 96.0)
Hip circumference (cm) 94.8 ± 10.7 (56.0 – 121.4) 96.6 ± 7.9 (78.1– 112.0)
Waist/Hip ratio† 0.87 ± 1.0 (0.66 – 1.41) 0.80 ± 0.07 (0.67 – 0.97)
Sistolic BP (mmHg) † 114.1 ± 10.1 (91.5 – 137.0) 107.3 ± 9.0 (89 – 136.5)
Diastolic BP (mmHg)* 57.6 ± 5.6 (44.0–74.0) 60.1 ± 6.5 (46.5 – 78.5)
Mean CIMT (mm) 0.379 ± 0.039 (0.286 – 0.478) 0.385 ± 0.045 (0.292 – 0.508)
CT Subcutaneous Fat (cm2) † 129.8 ± 95.9 (27.0 – 463.8) 200.1 ± 94.4 (42.2 – 417.3)
CT Visceral Fat (cm2) 27.7 ± 22.0 (2.6 – 122.5) 24.5 ± 15.0 (2.3 – 84.1)
CT Marrow fat density (g/cm3) † 0.979 ± 0.017 (0.915 – 1.036) 0.994 ± 0.021 (0.959 – 1.036)
Males Females
Means ± SD (range) Means ± SD (range)
Insulin (mU/l) * 4.0 ± 2.4 (1.0– 13.0) 5.2 ± 3.1 (1.0– 13.0)
Glucose (mg/dl)* 89.2 ± 7.4 (64.0 –103.0) 86.0 ± 5.8 (71.0 –104.0)
HOMA-IR* 0.9 ± 0.6 (0.2 – 3.1) 1.2 ± 0.7 (0.2 – 3.3)
Triglycerides (mg/dl) 85.2 ± 45.1 (19.0 – 234.0) 78.7 ± 34.2 (31.0 – 227.0)
Total Cholesterol (mg/dl) 150.2 ± 29.0 (82.0 – 257.0) 155.5 ± 25.5 (90.0 – 213.0)
HDL cholesterol (mg/dl)* 45.5 ± 10.3 (25.0 – 90.0) 52.4 ± 10.5 (30.0 – 77.0)
LDL cholesterol (mg/dl) 87.7 ± 25.2 (27.0 – 174.0) 87.4 ± 22.3 (24.0 – 146.0)
VLDL cholesterol (mg/dl) 17.0 ± 9.1 (4.0 – 47.0) 15.7 ± 6.8 (6.2 – 45.0)
LDL+VLDL cholesterol (mg/dl) 104.8 ± 28.7 (34.4 – 202.0) 103.2 ± 25.6 (35.2 – 167.0)
Ratio LDL+VLDL/HDL* 2.4 ± 0.9 (0.7 – 5.4) 2.1 ± 0.8 (0.6 – 5.0)
CRP (mg/dl) 2.1 ± 5.2 (0.2 – 30.5) 1.82 ± 2.72 (0.2 – 16.2)
BP blood pressure; CIMT carotid intima media thickness
*
P<0.05
†
P<0.0001
*
P<0.05
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Table 3
Multivariate regression analyses for marrow, visceral and subcutaneous fat prediction
Females Males
β P β P
Subcutaneous Fat Area
 BMI 19.26 <0.0001 18.23 <0.0001
 Waist/hip ratio -83.53 0.44 -82.48 0.19
 HOMA-IR -4.58 0.66 31.76 0.007
 (LDL+VLDL)/HDL 12.17 0.21 11.21 0.15
  R2adjusted 0.73 0.74
Visceral Fat Area
 BMI 2.11 <0.0001 3.14 <0.0001
 Waist/hip ratio 36.90 0.058 -16.83 0.36
 HOMA-IR -2.69 0.14 3.94 0.25
 (LDL+VLDL)/HDL 5.50 0.002 7.94 0.0009
  R2adjusted 0.66 0.57
Marrow Fat Density
 BMI 0.001 0.19 0.001 0.40
 Waist/hip ratio -0.068 0.15 -0.014 0.50
 HOMA-IR -4.546E-4 0.91 2.315E-4 0.93
 (LDL+VLDL)/HDL 8.754E-6 0.99 -8.591E-5 0.98
  R2adjusted - -
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